Gates Foundation set to fund African scientists in the malaria and TB fight

African scientists have managed to secure a significant boost in their efforts to combat malaria and tuberculosis, with a $7.2-million grant from medical research charity LifeArc and the Bill & Melinda Gates Foundation.

More than half of this funding is set to be allocated to discovering new treatments for these infectious diseases, according to statements from beneficiary universities such as Stellenbosch University, the University of Ghana, and the University of Pretoria.

The grant is particularly crucial for Africa, where these diseases have a profound impact on public health, productivity, and economic growth. Malaria claims the lives of approximately 600,000 people annually on the continent, with children under the age of five being the most vulnerable. The parasites causing malaria are known for their propensity to mutate, leading to drug resistance.

Tuberculosis, although preventable and curable, poses challenges due to the prolonged duration of existing treatments, which can take up to two years to eliminate the bacterial disease. The funding aims to support research teams in Africa and enhance the continent’s capacity to address these health challenges.

Kelly Chibale from the University of Cape Town expressed optimism about the grant, saying:  “The grant is a major leap forward towards building a critical mass of scientists fighting these diseases.”

This financial support is part of a broader initiative, aligning with the Gates Foundation’s commitment to global health. In October, the foundation allocated $40 million to fund mRNA research and manufacturing, focusing on assisting poorer countries in expanding their drug and vaccine supplies. This move is integral to fostering self-reliance in Africa’s healthcare infrastructure. The recent grant further underscores the collaborative efforts to develop effective strategies against malaria and tuberculosis, offering hope for improved healthcare outcomes on the continent.